RxDoctor Payments Data

Brittny Patterson

Psychiatric/Mental Health · Hutchinson, KSNPI 1477319838

Payments from drug & device makers

$1,018in general payments, 2019–2025

Across 58 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$223
  • Teva Pharmaceuticals USA, Inc.$139
  • Neurocrine Biosciences, Inc.$115
  • AbbVie$111
  • Otsuka America Pharmaceutical, Inc.$110
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$88
  • plus $232 from 8 others

What the payments were for

  • Food & beverage$1,018100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,018 in reported general payments places this provider in the 60th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$9,415
Medicare patients
38
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate49$156,977
VraylarCariprazine Hcl86$109,344
Aripiprazole103$21,366
CaplytaLumateperone Tosylate13$20,378
RexultiBrexpiprazole16$15,611
QelbreeViloxazine Hcl15$9,262
Quetiapine Fumarate ErQuetiapine Fumarate22$6,902
DepakoteDivalproex Sodium18$5,831
Olanzapine OdtOlanzapine18$5,478
Sertraline Hcl124$2,279
Paliperidone ErPaliperidone27$2,123
Oxcarbazepine37$2,096
Duloxetine Hcl68$1,860
Fluoxetine DrFluoxetine Hcl11$1,465
Lurasidone Hcl12$1,409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$223$156,97749 claims
AbbVieVraylar$111$109,34486 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$88$20,37813 claims
Otsuka America Pharmaceutical, Inc.Rexulti$110$15,61116 claims
Supernus Pharmaceuticals, Inc.Qelbree$14$9,26215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Hutchinson

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →